Bright Minds Biosciences (DRUG) Exchange Rate Effect (2020 - 2026)

Bright Minds Biosciences (DRUG) has 7 years of Exchange Rate Effect data on file, last reported at $1.0 million in Q1 2026.

• Quarterly Exchange Rate Effect rose 8938.63% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$932823.2 (down 177.98% YoY) and the FY2025 annual result came in at $227164.3, up 2544.09% from the prior year.
• Exchange Rate Effect climbed to $1.0 million in Q1 2026, from -$1.0 million in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $1.2 million in Q4 2024 to a low of -$1.0 million in Q4 2025.
• A 5-year average of $14624.7 and a median of $3943.3 in 2023 frame the typical range for Exchange Rate Effect.
• Annual changes were most pronounced in 2025 — Exchange Rate Effect tumbled 3263.82% — and 2026, when it jumped 8938.63%.
• Tracing DRUG's Exchange Rate Effect over 5 years: stood at $5193.0 in 2022, then plunged by 698.25% to -$31067.2 in 2023, then jumped by 3855.98% to $1.2 million in 2024, then tumbled by 188.23% to -$1.0 million in 2025, then jumped by 200.82% to $1.0 million in 2026.
• The last three Exchange Rate Effect figures came in at $1.0 million (Q1 2026), -$1.0 million (Q4 2025), and -$384416.1 (Q3 2025), per Business Quant data.